Human thymic lymphocyte culture with purified IgG showed that pooled IgG from patients with AD could more effectively modulate cytokine production from thymic CD4+ T cells than did polyvalent IgG from healthy human subjects (IVIg) (99). This evidence concerns the gene CD4 and Alzheimer disease.